CALGB 30704 (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0000000000000071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Efficacy and Safety of Pemetrexed-Based Doublet Therapy Compared to Pemetrexed Alone for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Updated Meta-Analysis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Phase I and Pharmacokinetic Study of Pemetrexed Plus Cisplatin in Chemonaive Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Long-Term Pemetrexed Administration in 22 Patients With Non-Small Cell Lung Cancer in a Japanese Phase II Randomized Study

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2009English

Phase I/Ii Trial of Pemetrexed Plus Nab-Paclitaxel in Advanced Solid Tumor Patients With Emphasis on Non-Small Cell Lung Cancer

Investigational New Drugs
OncologyPharmacology
2013English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

P1.01-40 Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly PTS With Untreated Advanced NSCLC: TORG1323

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy